The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in ...
WALTHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of four abstracts that ...
Stanicka says that when it comes to neuropathic pain, γ-aminobutyric acid (GABA ... many patients do not respond, or they become refractory to treatment. Stanicka pins the issues with GABA ...
New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of CARVYKTI to transform outcomes in refractory multiple myeloma ...
The Neurosurgery Department at the WVU Rockefeller Neuroscience Institute (RNI) recently implanted WVU Medicine’s first restorative neurostimulation therapy for low back pain.
Researchers at Memorial Sloan Kettering Cancer Center (“MSK”) developed DANYELZA® (naxitamab-gqgk), which is exclusively licensed by MSK to Y-mAbs. MSK has institutional financial interests in the ...